Antioxidative effects of statins

Archives of Toxicology

Volumn 82, Issue 12, 2008, Pages 885-892

  Adam, Oliver ^a   Laufs, Ulrich ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Endothelial dysfunction; Oxidative stress; Prevention; Review; Statin

Indexed keywords

APOLIPOPROTEIN A1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ANTIOXIDANT ACTIVITY; CHOLESTEROL SYNTHESIS; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HEART MUSCLE; HUMAN; HYPERCHOLESTEROLEMIA; ISOPRENYLATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; STROKE; ANIMAL; ENDOTHELIUM; METABOLISM; METHODOLOGY; SECONDARY PREVENTION; VASCULAR ENDOTHELIUM;

ANIMALS; CHOLESTEROL, LDL; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; SECONDARY PREVENTION;

EID: 59849107339     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-008-0344-4     Document Type: Review

References (79)

1. O Adam G Frost F Custodis MA Sussman HJ Schafers M Bohm U Laufs 2007 Role of Rac1 GTPase activation in atrial fibrillation J Am Coll Cardiol 50 359 367
2. R Aikawa I Komuro T Yamazaki Y Zou S Kudoh W Zhu T Kadowaki Y Yazaki 1999 Rho family small G proteins play critical roles in mechanical stress- induced hypertrophic responses in cardiac myocytes Circ Res 84 458 466
3. R Aikawa M Nawano Y Gu H Katagiri T Asano W Zhu R Nagai I Komuro 2000 Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt Circulation 102 2873 2879
4. S Amin-Hanjani NE Stagliano M Yamada PL Huang JK Liao MA Moskowitz 2001 Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice Stroke 32 980 986
5. TJ Anderson IT Meredith AC Yeung B Frei AP Selwyn P Ganz 1995 The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion N Engl J Med 332 488 493
6. TE Andreoli 2000 Free radicals and oxidative stress Am J Med 108 650 651
7. JK Bendall AC Cave C Heymes N Gall AM Shah 2002 Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice Circulation 105 293 296
8. CB Blum 1994 Comparison of properties of four inhibitors of 3-hydroxy-3- methylglutaryl-coenzyme A reductase Am J Cardiol 73 3D 11D
9. H Cai DG Harrison 2000 Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress Circ Res 87 840 844
10. H Cai Z Li A Goette F Mera C Honeycutt K Feterik JN Wilcox SC Dudley Jr DG Harrison JJ Langberg 2002 Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke Circulation 106 2764 2766
11. CA Carnes MK Chung T Nakayama H Nakayama RS Baliga S Piao A Kanderian S Pavia RL Hamlin PM McCarthy JA Bauer DR Van Wagoner 2001 Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation Circ Res 89 E32 E38
12. A Corsini FM Maggi AL Catapano 1995 Pharmacology of competitive inhibitors of HMG-CoA reductase Pharmacol Res 31 9 27
13. F Custodis M Eberl H Kilter M Böhm U Laufs 2006 Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy Cardiovasc Res 71 342 351
14. LJ Dixon DR Morgan SM Hughes LT McGrath NA El Sherbeeny RD Plumb A Devine W Leahey GD Johnston GE McVeigh 2003 Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure Circulation 107 1725 1728
15. SC Dudley Jr NE Hoch LA McCann C Honeycutt L Diamandopoulos T Fukai DG Harrison SI Dikalov J Langberg 2005 Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases Circulation 112 1266 1273
16. M Endres U Laufs 2006 Discontinuation of statin treatment in stroke patients Stroke 37 2640 2643
17. M Endres U Laufs 2008 The medical case for the development of an intravenous statin formulation-beyond ischemic stroke Cerebrovasc Dis 25 593 594
18. M Endres U Laufs Z Huang T Nakamura P Huang MA Moskowitz JK Liao 1998 Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase Proc Natl Acad Sci USA 95 8880 8885
19. O Feron C Dessy JP Desager JL Balligand 2001 Hydroxy-methylglutaryl- coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance Circulation 103 113 118
20. T Finkel 1999 Signal transduction by reactive oxygen species in non-phagocytic cells J Leukoc Biol 65 337 340
21. D Fulton JP Gratton TJ McCabe J Fontana Y Fujio K Walsh TF Franke A Papapetropoulos WC Sessa 1999 Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 597 601
22. WD Gao Y Liu E Marban 1996 Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle. Implications for the mechanism of stunned myocardium Circulation 94 2597 2604
23. JL Goldstein MS Brown 1990 Regulation of the mevalonate pathway Nature 343 425 430
24. JM Gutteridge B Halliwell 2000 Free radicals and antioxidants in the year 2000. A historical look to the future Ann NY Acad Sci 899 136 147
25. A Hall 1998 Rho GTPases and the actin cytoskeleton Science 279 509 514
26. DG Harrison 1997 Cellular and molecular mechanisms of endothelial cell dysfunction J Clin Invest 100 2153 2157
27. O Hernandez-Perera D Perez-Sala J Navarro-Antolin R Sanchez-Pascuala G Hernandez C Diaz S Lamas 1998 Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells J Clin Invest 101 2711 2719
28. C Heymes JK Bendall P Ratajczak AC Cave JL Samuel G Hasenfuss AM Shah 2003 Increased myocardial NADPH oxidase activity in human heart failure J Am Coll Cardiol 41 2164 2171
29. ES Istvan J Deisenhofer 2001 Structural mechanism for statin inhibition of HMG-CoA reductase Science 292 1160 1164
30. S John C Delles J Jacobi MP Schlaich M Schneider G Schmitz RE Schmieder 2001 Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks J Am Coll Cardiol 37 1351 1358
31. WH Kaesemeyer RB Caldwell J Huang RW Caldwell 1999 Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions J Am Coll Cardiol 33 234 241
32. YM Kim TJ Guzik YH Zhang MH Zhang H Kattach C Ratnatunga R Pillai KM Channon B Casadei 2005 A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation Circ Res 97 629 636
33. Y Kureishi Z Luo I Shiojima A Bialik D Fulton DJ Lefer WC Sessa K Walsh 2000 The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nat Med 6 1004 1010
34. U Landmesser N Engberding FH Bahlmann A Schaefer A Wiencke A Heineke S Spiekermann D Hilfiker-Kleiner C Templin D Kotlarz M Mueller M Fuchs B Hornig H Haller H Drexler 2004 Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase Circulation 110 1933 1939
35. B Lassegue D Sorescu K Szocs Q Yin M Akers Y Zhang SL Grant JD Lambeth KK Griendling 2001 Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways Circ Res 88 888 894
36. U Laufs 2003 Beyond lipid-lowering: effects of statins on endothelial nitric oxide Eur J Clin Pharmacol 58 719 731
37. U Laufs JK Liao 1998 Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase J Biol Chem 273 24266 24271
38. U Laufs L La Fata JK Liao 1997 Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase J Biol Chem 272 31725 31729
39. U Laufs V La Fata J Plutzky JK Liao 1998 Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1129 1135
40. U Laufs D Marra K Node JK Liao 1999 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down- regulation of p27(Kip1) J Biol Chem 274 21926 21931
41. U Laufs M Endres N Stagliano S Amin-Hanjani DS Chui SX Yang T Simoncini M Yamada E Rabkin PG Allen PL Huang M Böhm FJ Schoen MA Moskowitz JK Liao 2000 Neuroprotection mediated by changes in the endothelial actin cytoskeleton J Clin Invest 106 15 24
42. U Laufs S Wassmann S Hilgers N Ribaudo M Böhm G Nickenig 2001 Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men Am J Cardiol 88 1306 1307
43. U Laufs H Kilter C Konkol S Wassmann M Böhm G Nickenig 2002 Impact of HMG CoA reductase inhibition on small GTPases in the heart Cardiovasc Res 53 911 920
44. AP Lea D McTavish 1997 Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias Drugs 53 828 847
45. TM Lee TF Chou CH Tsai 2002 Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin f2alpha formation J Cardiovasc Pharmacol 40 868 874
46. JM Li AM Shah 2004 Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology Am J Physiol Regul Integr Comp Physiol 287 R1014 R1030
47. JM Li NP Gall DJ Grieve M Chen AM Shah 2002 Activation of NADPH oxidase during progression of cardiac hypertrophy to failure Hypertension 40 477 484
48. JK Liao 1994 Inhibition of Gi proteins by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide J Biol Chem 269 12987 12992
49. JK Liao 1998 Endothelium and acute coronary syndromes Clin Chem 44 1799 1808
50. JK Liao U Laufs 2005 Pleiotropic effects of statins Annu Rev Pharmacol Toxicol 45 89 118
51. JK Liao MA Bettmann T Sandor JI Tucker SM Coleman MA Creager 1991 Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis Circ Res 68 1027 1034
52. JK Liao JJ Zulueta FS Yu HB Peng CG Cote PM Hassoun 1995 Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen J Clin Invest 96 2661 2666
53. P Libby 1995 Molecular bases of the acute coronary syndromes Circulation 91 2844 2850
54. C Maack T Kartes H Kilter HJ Schäfers G Nickenig M Böhm U Laufs 2003 Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment Circulation 108 1567 1574
55. PA MacCarthy DJ Grieve JM Li C Dunster FJ Kelly AM Shah 2001 Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase Circulation 104 2967 2974
56. F McTaggart L Buckett R Davidson G Holdgate A McCormick D Schneck G Smith M Warwick 2001 Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Am J Cardiol 87 28B 32B
57. MJ Mihm F Yu CA Carnes PJ Reiser PM McCarthy DR Van Wagoner JA Bauer 2001 Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 174 180
58. T Munzel H Sayegh BA Freeman MM Tarpey DG Harrison 1995 Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance J Clin Invest 95 187 194
59. S Nattel P Khairy D Roy B Thibault P Guerra M Talajic M Dubuc 2002 New approaches to atrial fibrillation management: a critical review of a rapidly evolving field Drugs 62 2377 2397
60. G O'Driscoll D Green RR Taylor 1997 Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month Circulation 95 1126 1131
61. Y Rikitake S Kawashima S Takeshita T Yamashita H Azumi M Yasuhara H Nishi N Inoue M Yokoyama 2001 Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits Atherosclerosis 154 87 96
62. VW Rodwell JL Nordstrom JJ Mitschelen 1976 Regulation of HMG-CoA reductase Adv Lipid Res 14 1 74
63. K Strehlow S Rotter S Wassmann O Adam C Grohe K Laufs M Bohm G Nickenig 2003 Modulation of antioxidant enzyme expression and function by estrogen Circ Res 93 170 177
64. M Takemoto K Node H Nakagami Y Liao M Grimm Y Takemoto M Kitakaze JK Liao 2001 Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy J Clin Invest 108 1429 1437
65. O Tamai H Matsuoka H Itabe Y Wada K Kohno T Imaizumi 1997 Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans Circulation 95 76 82
66. M Tannous R Cheung A Vignini B Mutus 1999 Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects Thromb Haemost 82 1390 1394
67. N Tapon A Hall 1997 Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton Curr Opin Cell Biol 9 86 92
68. CB Treasure JL Klein WS Weintraub JD Talley ME Stillabower AS Kosinski J Zhang SJ Boccuzzi JC Cedarholm RW Alexander 1995 Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 481 487
69. T Tsunekawa T Hayashi H Kano D Sumi H Matsui-Hirai NK Thakur K Egashira A Iguchi 2001 Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days Circulation 104 376 379
70. M Ushio-Fukai AM Zafari T Fukui N Ishizaka KK Griendling 1996 p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells J Biol Chem 271 23317 23321
71. AL Van C D'Souza-Schorey 1997 Rho GTPases and signaling networks Genes Dev 11 2295 2322
72. GL Vega SM Grundy 1998 Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men Am J Cardiol 81 36B 42B
73. MC Verhaar PE Westerweel AJ van Zonneveld TJ Rabelink 2004 Free radical production by dysfunctional eNOS Heart 90 494 495
74. AH Wagner T Kohler U Ruckschloss I Just M Hecker 2000 Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation Arterioscler Thromb Vasc Biol 20 61 69
75. S Wassmann U Laufs AT Bäumer K Müller K Ahlbory W Linz G Itter R Rösen M Böhm G Nickenig 2001 HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species Hypertension 37 1450 1457
76. S Wassmann U Laufs AT Bäumer K Müller C Konkol H Sauer M Böhm G Nickenig 2001 Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase Mol Pharmacol 59 646 654
77. S Wassmann A Faul B Hennen B Scheller M Böhm G Nickenig 2003 Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function Circ Res 93 e98 e103
78. JK Williams GK Sukhova DM Herrington P Libby 1998 Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys J Am Coll Cardiol 31 684 691
79. L Xiao DR Pimentel J Wang K Singh WS Colucci DB Sawyer 2002 Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes Am J Physiol Cell Physiol 282 C926 C934